A pharmacist who is a member of a managed care formulary evaluation committee is evaluating whether to include on the formulary a newly marketed drug. The drug is much more expensive than other drugs in its class and is rated by the FDA as type 5 and S. If you were the pharmacist, explain why you would or would not include the drug on the formulary.